International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies

Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity

(2015) H. Enocsson et al.   JOURNAL OF RHEUMATOLOGY

Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies

(2015) Maria Infantino et al.   Journal of Immunology Research

Evaluation of the Incidence of Discoid Lupus Erythematosus in Patients with Systemic Lupus Erythematosus and Its Relationship to Disease Activity

(2015) Massoud Saghafi et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

Clinical performance evaluation of a novel, automated chemiluminescent immunoassay, QUANTA Flash CTD Screen Plus

(2014) Chelsea Bentow et al.   IMMUNOLOGIC RESEARCH

Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus

(2014) J-Y Choe et al.   LUPUS

Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens

(2013) Chelsea Bentow et al.   CLINICA CHIMICA ACTA

Changes in Farr radioimmunoassay and EliA fluorescence immunoassay anti-dsDNA in relation to exacerbation of SLE

(2013) JJG Hillebrand et al.   LUPUS

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

(2012) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies

(2012) M. Mahler et al.   CLINICA CHIMICA ACTA

Comparison of three anti-dsDNA assays: Performance and correlation with systemic lupus erythematosus disease activity

(2012) Allison A. Venner et al.   CLINICAL BIOCHEMISTRY

Flare, Persistently Active Disease, and Serologically Active Clinically Quiescent Disease in Systemic Lupus Erythematosus: A 2-Year Follow-Up Study

(2012) Fabrizio Conti et al.   PLoS One

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM

Significant differences in the analytic concordance between anti-dsDNA IgG antibody assays for the diagnosis of systemic lupus erythematosus—Implications for inter-laboratory testing

(2011) Tyson R. Chiaro et al.   CLINICA CHIMICA ACTA

The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients

(2011) C.-S. Yee et al.   RHEUMATOLOGY

Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4

(2011) Heikki Julkunen et al.   RHEUMATOLOGY INTERNATIONAL

Epitope specificity and significance in systemic autoimmune diseases

(2010) Michael Mahler et al.   Annals of the New York Academy of Sciences

Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test

(2010) A. Antico et al.   LUPUS

BioPlex™ 2200 multiplexed system: Simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus

(2009) Nathalie Bardin et al.   AUTOIMMUNITY

Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus

(2009) John G. Hanly et al.   JOURNAL OF IMMUNOLOGICAL METHODS